How microglia age: seen at the cellular level for the first time
The brain has its own immune cells, called microglia, and it turns out they age very differently from what scientists assumed. New research shows for the first time how aging plays out inside the cell, not just on the outside.
Microglia are the brain's guardians. They clear away waste, respond to infections, and help maintain synapses. Scientists have long known that these cells change in appearance as they get older: they retract their branches, become rounder, and grow less active. But what actually happens at the molecular level has barely been studied. A new paper published in Nature Aging is changing that.
Researchers from the Henze group combined two techniques that are rarely used together. The first, MERFISH (multiplexed error-robust fluorescence in situ hybridization), lets you image hundreds of genes simultaneously within a single cell and pinpoint exactly where the RNA sits inside it. Not just which genes are active, but whether their transcripts cluster near the nucleus, toward the cell membrane, or out in the branches. The second technique, fluorescent immunohistochemistry, labels specific proteins to reveal the cell's physical structure. Together, they produce a detailed, three-dimensional portrait of a microglial cell at the moment aging takes hold.
RNA on the move, and what it means
What the team found is that RNA does not sit randomly inside microglia. In young cells, transcripts linked to immune activation occupy specific locations, presumably so they can be rapidly translated into proteins whenever the need arises. In older microglia, that spatial organization breaks down. Transcripts that normally sit at the cell's periphery turn up near the nucleus instead. Others vanish from the branches altogether. The pattern suggests that aging microglia do not simply become less active; they also become less orderly at the subcellular scale.
That could have major implications for our understanding of neurodegenerative disease. In Alzheimer's and Parkinson's, microglia play a central role: they can protect the brain, but they can also make damage worse. Until now, researchers assumed it was mainly the number or subtype of microglia that made the difference. This study points to a third factor: the internal organization of the cell itself. A microglial cell that looks perfectly normal from the outside may already be deeply disordered within.
A new way to measure brain aging
The researchers suggest that subcellular transcript patterns could potentially serve as early biomarkers of brain aging, detectable before any visible structural changes appear. That would open up diagnostic possibilities that simply do not exist today. The method is labor-intensive and requires specialized equipment, however, so clinical applications are still a long way off.
There is also an important caveat: the study was carried out in mice. Whether the same subcellular patterns hold for human microglia, and whether they correlate just as strongly with cognitive decline, remains unknown. The technique is there; now researchers need to find out whether the findings hold up in human brain tissue.